Patients selecting mechanical heart valve replacements are typically required to monitor their INR levels (international normalized ratio) to prevent risks of blood clotting, haemorrhage or stroke.To ease this process, home
At Dfine Bioinnovations, our R&D team is tirelessly pushing the boundaries of innovation to support diagnostics with cutting-edge, yet cost-effective solutions. Building on the success of Zeta-1, we are gearing up to launch Zeta-2, a two-channel semi-automatic coagulation analyzer designed to enhance efficiency and throughput for small to mid-size labs. Beyond this, we are exploring advanced automation and Point-of-Care Testing (POCT) solutions to offer a comprehensive range of diagnostic tools. These upcoming products underscore our commitment to revolutionizing healthcare with indigenous, affordable, and efficient innovations. Stay tuned for the next wave of transformative diagnostic technologies!
Instrument performance is directly tied to the quality of consumables, especially in critical diagnostic tests like coagulation. To ensure precision and reliability, Dfine Bioinnovations manufactures high-quality consumables such as buffer bottles, cuvettes, and stainless steel balls. These consumables not only support our flagship Zeta-1 coagulation analyzer but are also other devices like XL-1000, MC-1, and KC Series, ensuring consistent performance across platforms. By offering durable, efficient, and precision-engineered consumables, we are setting new standards in diagnostic accuracy and reliability, meeting the needs of labs globally.
FibriTimer Zeta-1 has undergone rigorous internal and external validation to ensure accuracy, reliability, and precision in its performance. Tested across leading labs and hospitals, it has demonstrated exceptional correlation and reproducibility for critical tests like PT/APTT. With its validation results published in the International Journal of Health Technology and Innovation (August 2024 issue), Zeta-1 stands as a trusted solution, empowering labs with dependable diagnostics and boosting confidence in patient care.
Dual Technology enhances lab efficiency by offering flexibility in result verification, especially for difficult samples. It boosts reporting confidence, expands test options on a single platform, and empowers small to mid-size labs by eliminating the need for multiple instruments for different tests and avoiding outsourcing. This leads to cost reduction and faster, more efficient reporting for timely patient treatment. Company has received Indian Patent(Patent no: 529922) for this technology.